Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
lol. Digging deep for that one. Dismissed
Whatever helps you sleep at night.
Live by the sword, die by the sword.
Do you really expect them to admit failure after decades of force feeding the public?
Funny how same could be said about obesity as well, and here we are with the rich abusing the hell out of said pills.
It’s one of the better off topic comments though. I’ll give em that.
Sooo much bettter than the constant doom and gloom
Concur.
The signal was given, the shorts were in control, and then the cover signal was given.
Up to the upper $4s we go
Always the negative Nancy.
Obviously, the greater healthcare system needs to know there is something better than targeting and removing plaques.
Like salmon swimming upstream. I surely expect Anavex to have the last laugh ONE day.
When that day is, is beyond anyone on this board.
Can’t disagree with you on the 3rd and 4th sentences.
Funny how a trial can fail yet seem to be better than what’s been approved in EVERY aspect.
If only there were a side effect so obvious like diarrhea for the caregivers to know if they have the real deal.
In your own words. TBD
First statement is true.
Absolutely Nothing wrong. Just a tiny pre-revenue bio trying to swim through shark infested water.
I am curious though….how many of the tickets AF mouths about are on their list.
Funny. So more credence is given to another frivolous lawsuit than what the co has released to date?
Exactly how many tickers does this make that they are “suing”…..and that’s just 1 day.
Yea.It’s just another vehicle used by “those” guys.
You know it’s a FAKE lawsuit when in the lawsuit Adam is quoted.
Not even worth linking …just the reply
lol….its supposed to be in pennyland since when……2016 right?
Worse than George, cause at least he is correct once in a while.
There’s nothing to discuss at the moment. Just a bunch of pumpers and shorts yelling at each other nowadays
And where did you get THAT information from…..hmmmmmm
Obviously not. Just ask BIIB
Efficacy meaning:”In medical terms, efficacy refers to the ability of a product or treatment to provide a beneficial effect.”
Up to 4 weeks, you are saying the patient benefits from the therapy. At week 5, they don’t fully benefit, but maintain…..?
So for the Rett trial participants, they are simply maintaining their level of decline, of course unless they STILL have a placebo effect….?
I’ll give up on trying to understand after this post. Everyone has their opinions and I like to have an open mind on most.
How about 4 weeks of improvement, leveling off, then everything downstream start functioning more normally?
To say after 4 weeks all benefit has been had is hard to believe.
Then again, I’ll believe it if/when the full data set for any recently ended trial is released.
To be fair, Tom was calling $10s when we were in the $20s and I remember all the flack he got about it.
I appreciate what he sees using the set of tools he uses.
It doesn’t mean it’s what will happen, but at least it’s informative.
Which is more than the kindergarten talk we have today.
That is NOT what the horse said. Let me quote it for you.
“That is a very good point, and it’s exactly a possibility. And again, we would not do that, however, without further get regulatory input, because we might get some feedback, which could be very favorable. But indeed, that is something which could be done very easily. It’s a 12-week study, it’s not too long. And we have, again, a strong interest from the community, given the strong interest, and to continue to stay on study drug and patients in Rett syndrome from our program have been now on this drug for over four years – up to four years. That really shows a very high sticky interest to keep our drug and not to switch to anything else in the meantime.”
Why would patients that completed the trial enroll in another trial and risk being in the placebo group when they are already on the therapy for how many years?
They would need an entirely new set of patients.
One thing I wish Missling would stop doing is allowing participants to continue taking the therapy endlessly even after the trials are done.
Either it works or doesn’t. If it does, allow the groups to put pressure on the FDA.
No sense continuing giving them anything if it doesn’t work.
Thoughts?
I know I know….that data collected……
A good 1/4 -1/2 of all posters are.
Big $$ in play. Keep the SP down is the name of the game.
Gotta be worth it for someone….
1/4 the float….
He literally PR the P3 pediatric Rett trial didn’t meet its primary endpoint in a timely manner. Of course, that doesn’t fit the narrative though of Always.
Then there’s this:
ANAVEX®2-73 (BLARCAMESINE) PHASE 2B/3 STUDY MET PRIMARY AND KEY SECONDARY ENDPOINTS:
Robust, Statistically Significant and Clinically Meaningful Absolute Improvement in Cognitive Function as Measured by ADAS-Cog and ADCS-ADL
Where did it say primary and secondary endpoints failed?
We don’t know how it looks since the Rett PR on the second of Jan though.
Abroad…. 75%
If there were only a way that a majority vote could ban those type users.
Such as the below posted over a year ago?
“ANAVEX®2-73 (BLARCAMESINE) PHASE 2B/3 STUDY MET PRIMARY AND KEY SECONDARY ENDPOINTS,”
Let me fix that last sentence for you
Walk in Dr office take test, get script filled via Amazon pharmacy!Voila
Worldwide delivery straight to the door.
At this moment, I’d take a co PR over some anonymous board poster
“Robust, Statistically Significant and Clinically Meaningful Absolute Improvement in Cognitive Function as Measured by ADAS-Cog and ADCS-ADL”
Anavex would be DONE, if that statement doesn’t hold true.
Last sentence is obviously flawed. The co. PR’d that AD P2/3 not only was successful, but that it was stat sig.
Lie. BIIB got that trash approved on garbage post hock cherry picking data
Everyone has their own opinions.
Good luck to you and your future investments. Hope to see you pop your head in when the peer review finally gets released. Always looked forward to your thoughts.
Come on Bio. If Missling knows what the data is, he can’t purchase. You know that.
In the long run, both will be approved.
Both have not even begun to be baked into the SP
I suggest you buy enough shares and vote against them being renominated for their position.
Funny how it’s voted on, and they ALL seem to be doing a good enough job to continue on.